NASDAQ:NUTX
Nutex Health, Inc.
- Stock
Last Close
121.74
06/11 21:00
Market Cap
21.58M
Beta: -
Volume Today
153.73K
Avg: 1.69M
PE Ratio
−0.01
PFCF: 16.66
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 13.54K - | 463.49K 3,324.03% | 1.31M 183.24% | 2.27M 72.91% | 3.17M 39.82% | 3.46M 9.08% | ||
average payables | 2.64M - | 6.96M 163.24% | 13.14M 88.85% | 22.59M 71.91% | 26.41M 16.88% | |||
average receivables | 10.56K - | 18.08M 171,042.58% | 72.14M 299.06% | 111.45M 54.49% | 86.54M 22.35% | 60.55M 30.03% | ||
book value per share | 0.03 - | 0.01 69.69% | 0.04 412.47% | 0.13 203.10% | 0.18 33.62% | 0.15 15.22% | 0.09 38.45% | |
capex per share | -0.05 - | -0.10 89.59% | -0.06 39.65% | -0.02 59.82% | -0.01 37.69% | |||
capex to depreciation | -13.03 - | -10.27 21.20% | -4.82 53.06% | -1.11 76.88% | -0.54 51.55% | |||
capex to operating cash flow | -2.66 - | -0.75 71.71% | -0.21 71.72% | -0.29 35.80% | -7.56 2,514.14% | |||
capex to revenue | -0.33 - | -0.22 32.70% | -0.11 50.23% | -0.07 40.09% | -0.04 42.53% | |||
cash per share | 0.00 - | 0.00 97.73% | 0.01 484,066.34% | 0.04 218.76% | 0.06 41.56% | 0.05 3.83% | 0.03 38.33% | |
days of inventory on hand | 158.62 - | 197.77 24.68% | 346.17 75.04% | 6.75 98.05% | 6.27 7.14% | 5.81 7.21% | ||
days payables outstanding | 1.16K - | 1.73K 49.00% | 42.32 97.56% | 48.82 15.35% | 43.35 11.20% | |||
days sales outstanding | 42.55 - | 59.40 39.61% | 135.91 128.78% | 144.36 6.22% | 126.34 12.48% | 97.06 23.18% | 92.52 4.67% | |
debt to assets | 0.02 - | 0.18 693.38% | 0.67 278.69% | 0.49 27.30% | 0.45 7.01% | 0.62 36.79% | 0.12 81.18% | |
debt to equity | 0.03 - | 0.37 1,098.83% | 4.24 1,029.80% | 1.75 58.71% | 1.56 10.98% | 2.79 78.98% | 0.75 72.92% | |
dividend yield | 0.00 - | 0.00 212.39% | 0.01 144.43% | 0.04 657.67% | ||||
earnings yield | 0.00 - | -0.00 381.55% | 0.00 230.73% | 0.00 511.62% | 0.01 31.52% | -0.36 7,066.74% | -0.38 7.23% | |
enterprise value | 3.35B - | 5.75B 71.74% | 25.86B 349.93% | 25.87B 0.05% | 25.89B 0.07% | 1.44B 94.44% | 372.78M 74.10% | |
enterprise value over ebitda | -587.91 - | -3.14K 434.09% | 678.82 121.62% | 163.81 75.87% | 138.53 15.43% | 180.05 29.97% | 22.87 87.30% | |
ev to operating cash flow | -4.74K - | -7.51K 58.26% | 2.13K 128.41% | 318.39 85.07% | 149.29 53.11% | 28.44 80.95% | 296.69 943.26% | |
ev to sales | 62.39K - | 62.91K 0.83% | 266.46 99.58% | 94.63 64.49% | 78.10 17.47% | 6.56 91.60% | 1.51 77.06% | |
free cash flow per share | -0.01 - | -0.01 36.81% | -0.03 487.57% | 0.03 199.61% | 0.21 580.07% | 0.06 73.28% | -0.01 121.99% | |
free cash flow yield | -0.00 - | -0.00 36.81% | -0.00 487.57% | 0.00 199.61% | 0.01 580.07% | 0.03 462.56% | -0.07 332.14% | |
graham net net | -0.01 - | -0.01 16.23% | -0.14 1,423.10% | -0.08 42.15% | -0.12 47.98% | -0.36 195.57% | -0.38 2.93% | |
graham number | 0.07 - | 0.06 7.62% | 0.16 158.84% | 0.69 330.56% | 0.91 32.56% | 1.52 67.50% | 0.38 74.99% | |
income quality | -1.21 - | 0.27 122.44% | 0.38 38.91% | 0.56 47.76% | 1.03 84.33% | -0.12 111.36% | -0.03 76.53% | |
intangibles to total assets | 0.98 - | 0.98 0.07% | 0.01 99.35% | 0.00 41.91% | 0.00 25.03% | 0.09 1,816.59% | 94.36 106,545.15% | |
interest coverage | 15.50 - | 2.85 81.60% | 9.83 244.84% | 23.68 140.86% | 27.48 16.05% | -0.41 101.50% | -0.08 80.76% | |
interest debt per share | -0.00 - | -0.00 64.32% | 0.19 15,436.59% | 0.24 26.79% | 0.29 18.01% | 0.44 53.50% | 0.09 78.47% | |
inventory turnover | 2.30 - | 1.85 19.80% | 1.05 42.87% | 54.10 5,031.01% | 58.26 7.68% | 62.78 7.77% | ||
invested capital | 0.03 - | 0.37 1,098.83% | 4.24 1,029.80% | 1.75 58.71% | 1.56 10.98% | 2.79 78.98% | 0.75 72.92% | |
market cap | 3.35B - | 5.75B 71.72% | 25.75B 348.02% | 25.75B 0% | 25.75B 0% | 1.21B 95.32% | 119.02M 90.13% | |
net current asset value | -904.70K - | -1.34M 48.46% | -82.65M 6,053.20% | -25.68M 68.93% | -49.05M 91.03% | -213.45M 335.14% | -228.29M 6.95% | |
net debt to ebitda | -0.01 - | -0.25 2,122.34% | 2.94 1,264.14% | 0.79 73.15% | 0.76 3.40% | 29.14 3,724.00% | 15.57 46.58% | |
net income per share | 0.01 - | -0.02 381.55% | 0.03 230.73% | 0.16 511.62% | 0.21 31.52% | -0.68 430.92% | -0.07 89.84% | |
operating cash flow per share | -0.01 - | -0.01 36.81% | 0.02 453.54% | 0.13 570.24% | 0.27 113.42% | 0.08 70.41% | 0.00 97.62% | |
payables turnover | 0.31 - | 0.21 32.89% | 8.62 3,990.86% | 7.48 13.31% | 8.42 12.61% | |||
receivables turnover | 8.58 - | 6.14 28.37% | 2.69 56.29% | 2.53 5.85% | 2.89 14.26% | 3.76 30.17% | 3.94 4.90% | |
research and ddevelopement to revenue | 0.01 - | 0.00 74.25% | 0.00 57.69% | |||||
return on tangible assets | 9.88 - | -63.34 741.22% | 0.09 100.15% | 0.33 254.31% | 0.34 2.92% | -1.10 425.77% | 0.00 100.11% | |
revenue per share | 0.00 - | 0.00 0.82% | 0.15 23,608.81% | 0.42 181.71% | 0.52 21.25% | 0.35 32.93% | 0.37 8.43% | |
roe | 0.25 - | -2.28 1,028.93% | 0.58 125.51% | 1.17 101.79% | 1.16 1.57% | -4.51 490.33% | -0.75 83.49% | |
roic | -2.33 - | -1.08 53.66% | 0.08 107.72% | 0.35 316.67% | 0.44 27.40% | -0.01 102.02% | -0.00 61.67% | |
sales general and administrative to revenue | 33.81 - | 12.74 62.33% | 0.62 95.16% | 0.42 31.74% | 0.02 96.09% | 0.08 399.04% | 0.13 63.19% | |
shareholders equity per share | 0.03 - | 0.01 69.69% | 0.04 412.47% | 0.13 203.10% | 0.18 33.62% | 0.15 15.22% | 0.09 38.45% | |
stock based compensation to revenue | 17.23 - | 2.28 86.79% | 0.00 99.80% | 0.01 102.84% | 0.00 - | 0.01 1,224.65% | ||
tangible asset value | -900.86K - | -1.34M 48.86% | 49.70M 3,805.87% | 146.23M 194.25% | 189.76M 29.77% | 82.13M 56.72% | -37.50B 45,761.64% | |
tangible book value per share | -0.01 - | -0.01 13.31% | 0.07 901.60% | 0.23 203.63% | 0.29 29.77% | 0.13 56.12% | -30.93 24,008.61% | |
working capital | -904.70K - | -1.34M 48.46% | -26.39M 1,864.78% | 104.06M 494.31% | 116.32M 11.79% | 43.11M 62.94% | 32.54M 24.53% |
All numbers in USD (except ratios and percentages)